New research in biosimilars: oncology barriers, PFS handling, and Australian policy

Author(s): Robin Thorpe, PhD, FRCPath

In this third issue of 2025, we have pub- lications which include two editorials and three original research papers. All are in the biosimilars area and once more we have no papers dealing with generics. We strongly encourage potential authors of manuscripts in the generics field as well as those on biosimilars to submit them […]

Read more →